| RS1169689300 |
NDUFS6
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1169717734 |
UGT1A1
|
Health Risk |
Likely pathogenic |
Gilbert syndrome, Gilbert syndrome |
| RS1169744090 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS116974943 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS1169752185 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS116977551 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS1169783208 |
OCA2
|
Health Risk |
Pathogenic |
Tyrosinase-positive oculocutaneous albinism, OCA2-related disorder |
| RS1169800424 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS116980451 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1169809892 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1169822437 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder 6A (Zellweger) |
| RS1169850759 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 3, Age related macular degeneration 2 |
| RS116985497 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, HLCS-related disorder |
| RS1169861687 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, PCCA-related disorder |
| RS1169866178 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS116987552 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS1169875761 |
CPT1A
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1169880026 |
NTRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, hyperphagia |
| RS116988549 |
PKD1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1169894160 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1169898186 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1169912956 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1169917994 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS1169927428 |
PRORP
|
Health Risk |
Pathogenic/Likely pathogenic |
Perrault syndrome 1, Combined oxidative phosphorylation deficiency 54 |
| RS1169938399 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1169954783 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Childhood onset hearing loss, Childhood onset hearing loss |
| RS1169959260 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1169967969 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS116998555 |
WNT10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Schöpf-Schulz-Passarge syndrome, Odonto-onycho-dermal dysplasia |
| RS1170011808 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS117001332 |
TPSG1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1170028069 |
MAT1A
|
Health Risk |
Pathogenic |
— |
| RS1170038377 |
SLC39A7
|
Health Risk |
Pathogenic |
Agammaglobulinemia 9, autosomal recessive |
| RS1170041461 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS1170047320 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS1170049553 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS117005078 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Meniere disease, Meniere disease |
| RS1170064033 |
LAMC3
|
Health Risk |
Likely pathogenic |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS1170069201 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome, Cowden syndrome 5 |
| RS1170091784 |
RNF43
|
Health Risk |
Likely pathogenic |
— |
| RS117012322 |
ECEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1170128038 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1170138989 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 8, Inborn genetic diseases |
| RS1170149970 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS117016551 |
WNK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS117017152 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1170194230 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS1170201571 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS1170204399 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS11702055 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Melanoma |
| RS117021471 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1170222257 |
NDRG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1170254952 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1170262447 |
TRIM37
|
Health Risk |
Pathogenic/Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS1170311490 |
PIGW
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 5, Hyperphosphatasia with intellectual disability syndrome 5 |
| RS1170313629 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |
| RS1170321638 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS1170323988 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS117033008 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS117034581 |
TSPEAR
|
Health Risk |
Conflicting classifications of pathogenicity |
TSPEAR-related disorder, TSPEAR-related disorder |
| RS1170362213 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1170363408 |
LZTR1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1170374164 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1170385434 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1170393191 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1170410040 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1170413397 |
ASPM
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Microcephaly 5 |
| RS1170430756 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1170446813 |
PNPLA1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 10, Autosomal recessive congenital ichthyosis 10 |
| RS1170451277 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
CEP290-related disorder, Meckel-Gruber syndrome |
| RS1170466474 |
SMN1
|
Health Risk |
Likely pathogenic |
— |
| RS1170509653 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, Autism spectrum disorder |
| RS1170510043 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS1170510858 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS117056541 |
TBX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian syndromes with cleft lip/palate, TBX10-related disorder |
| RS117056996 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Laryngo-onycho-cutaneous syndrome, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1170578408 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1170589314 |
MID2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1170598133 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1170628768 |
CHRNA7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS117063344 |
MCM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency, Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency |
| RS1170665581 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1170676998 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1170679293 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS117067974 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS117071200 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS117072049 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Myopathy |
| RS11707242 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1170730150 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1170732591 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1170743406 |
PNKP
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1170758603 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS117079110 |
HPD
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type III, Hawkinsinuria |
| RS1170792905 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1170796077 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS1170817007 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1170821828 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1170836879 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1170836959 |
CRTAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1170838072 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |